WVE — Wave Life Sciences, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1631574 ·
Last close
$2.84
Market Cap
$560.13M
52W High
$21.73
52W Low
$2.77
ADV30
2,910,815
Next earnings
2026-10-27

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 13,158,000 — -66,047,000 -61,912,000 507,930,000 197,315,000 105,994,000
Jun 2026 2,272,000 — -73,802,000 -69,355,000 558,321,000 368,008,000 104,801,000
Mar 2026 38,246,000 — -31,298,000 -26,087,000 583,544,000 544,591,000 71,814,000
Dec 2025 17,245,000 — -56,467,000 -53,179,000 638,499,000 602,068,000 120,142,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-207,053,000
Investing CF
$-234,750,000
Financing CF
$442,985,000
CapEx
$-1,585,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.07
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,483,590,000
Inventory
—
Receivables
$12,000,000
ST Investments
$233,434,000
EBIT TTM
$-227,614,000
Pretax Income TTM
$-210,533,000
Interest Exp TTM
—
Analysts
19

Yahoo Snapshot (yfinance, live)

Total Revenue
$70,921,000
EBITDA
$-224,190,000
Free Cash Flow
$-132,660,128
Enterprise Value
$320,573,984
Total Cash
$430,748,992
Total Debt
$43,271,000
Shares Out
197,228,968
Trailing EPS
$-1.07
Book Value
$2.04
ROE
-78.8%
ROA
-38.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 42,727,000 -215,383,000 -204,378,000 638,499,000 120,142,000 518,357,000 -187,493,000
Dec 2024 108,302,000 -110,403,000 -97,008,000 352,207,000 142,692,000 209,515,000 -151,026,000
Dec 2023 113,305,000 -67,996,000 -57,513,000 274,949,000 235,319,000 39,630,000 -19,431,000
Dec 2022 3,649,000 -162,720,000 -161,823,000 146,386,000 191,477,000 -45,091,000 -127,781,000

TTM Snapshot

Revenues TTM
$65,371,000
NetIncome TTM
$-202,473,000
OpCashFlow TTM
—
Assets (Latest)
$558,321,000
Forward EPS
$-1.16

Max Pain — expiry 2028-01-21

max pain strike: $3.00 · spot: $2.77 · call oi: 2,457 · put oi: 690
Expected Move to 2028-01-21: ±$1.84 (66.43%) — implied range $0.93 – $4.61 · ATM straddle on $3.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ZVRA ZEVRA THERAPEUTICS, INC. $559.34M $9.40 —
ANL Adlai Nortye Group Ltd. $556.80M $9.48 —
AVBP ArriVent BioPharma, Inc. $552.92M $10.69 —
CLYM Climb Bio, Inc. $574.46M $9.78 —
ACRS Aclaris Therapeutics, Inc. $536.11M $3.38 —

News headlines (Yahoo Finance, 1h cache)

WAVE Life Sciences Targets Genetic Liver Disease With WVE-008 RNA Editing Program
2026-11-04 19:14 · Yahoo
Wave Life Sciences Ltd. Q3 2026 Earnings Call Summary
2026-10-28 00:30 · Yahoo
Wave Life Sciences (WVE) Q3 2026 Earnings Call Transcript
2026-10-27 18:58 · Yahoo
WAVE Life Sciences Q3 Earnings Call Highlights
2026-10-27 17:05 · Yahoo
Wave Life Sciences (WVE) Reports Q3 Loss, Tops Revenue Estimates
2026-10-27 11:40 · Yahoo
Wave Life Sciences: Q3 Earnings Snapshot
2026-10-27 11:35 · Yahoo
WAVE Life Sciences Highlights Obesity Data, FDA-Aligned RNA Editing Path
2026-10-22 03:02 · Yahoo
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026
2026-10-20 12:30 · Yahoo
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
2026-10-19 12:30 · Yahoo
Wave Life Sciences (WVE) Stock Fair Value Moves Lower As Analysts Cut Growth Views
2026-10-17 10:11 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.